Stereotactic core needle biopsy of multiple sites in the breast: Efficacy and effect on patient care

Ruth Rosenblatt, Susan A. Fineberg, Joseph A. Sparano, Ronald N. Kaleya

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

PURPOSE: To evaluate the efficacy and effect on patient care of performing stereotactic core needle biopsy of more than one site in the presence of multiple breast lesions. MATERIALS AND METHODS: Twenty-five patients underwent stereotactic core needle biopsy of more than one site. Histologic findings at core biopsy were correlated with mammographic findings, subsequent surgical results, and clinical follow-up. RESULTS: The final pathologic results were malignant in 15 (60%) patients. Invasive duct carcinoma or duct carcinoma in situ or both were diagnosed at more than one site and necessitated mastectomy in 10 patients (group I). Benign lesions were found at all sites in 10 patients (group II). Duct carcinoma in situ at only one site or atypical duct hyperplasia at one or more sites was documented in three patients, two of whom underwent breast conservation surgery (group III). Multisite stereotactic core needle biopsy had a positive effect on patient care in 20 (80%) of 25 patients by either helping to confirm the need for mastectomy without requiring needle localization biopsy (group I) or by documenting benign disease and sparing the patient needle localization biopsy at one or more sites (group II). CONCLUSION: Multisite stereotactic core needle biopsy is feasible, safe, and may influence treatment in patients with multiple mammographic abnormalities.

Original languageEnglish (US)
Pages (from-to)67-70
Number of pages4
JournalRadiology
Volume201
Issue number1
StatePublished - Oct 1996

Fingerprint

Large-Core Needle Biopsy
Patient Care
Breast
Mastectomy
Carcinoma in Situ
Needle Biopsy
Multiple Abnormalities
Hyperplasia
Carcinoma
Biopsy

Keywords

  • Breast neoplasms, diagnosis
  • Breast, biopsy
  • Breast, surgery
  • Stereotaxis

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Stereotactic core needle biopsy of multiple sites in the breast : Efficacy and effect on patient care. / Rosenblatt, Ruth; Fineberg, Susan A.; Sparano, Joseph A.; Kaleya, Ronald N.

In: Radiology, Vol. 201, No. 1, 10.1996, p. 67-70.

Research output: Contribution to journalArticle

Rosenblatt, Ruth ; Fineberg, Susan A. ; Sparano, Joseph A. ; Kaleya, Ronald N. / Stereotactic core needle biopsy of multiple sites in the breast : Efficacy and effect on patient care. In: Radiology. 1996 ; Vol. 201, No. 1. pp. 67-70.
@article{80feabc67361424fbfbceae618ff13c6,
title = "Stereotactic core needle biopsy of multiple sites in the breast: Efficacy and effect on patient care",
abstract = "PURPOSE: To evaluate the efficacy and effect on patient care of performing stereotactic core needle biopsy of more than one site in the presence of multiple breast lesions. MATERIALS AND METHODS: Twenty-five patients underwent stereotactic core needle biopsy of more than one site. Histologic findings at core biopsy were correlated with mammographic findings, subsequent surgical results, and clinical follow-up. RESULTS: The final pathologic results were malignant in 15 (60{\%}) patients. Invasive duct carcinoma or duct carcinoma in situ or both were diagnosed at more than one site and necessitated mastectomy in 10 patients (group I). Benign lesions were found at all sites in 10 patients (group II). Duct carcinoma in situ at only one site or atypical duct hyperplasia at one or more sites was documented in three patients, two of whom underwent breast conservation surgery (group III). Multisite stereotactic core needle biopsy had a positive effect on patient care in 20 (80{\%}) of 25 patients by either helping to confirm the need for mastectomy without requiring needle localization biopsy (group I) or by documenting benign disease and sparing the patient needle localization biopsy at one or more sites (group II). CONCLUSION: Multisite stereotactic core needle biopsy is feasible, safe, and may influence treatment in patients with multiple mammographic abnormalities.",
keywords = "Breast neoplasms, diagnosis, Breast, biopsy, Breast, surgery, Stereotaxis",
author = "Ruth Rosenblatt and Fineberg, {Susan A.} and Sparano, {Joseph A.} and Kaleya, {Ronald N.}",
year = "1996",
month = "10",
language = "English (US)",
volume = "201",
pages = "67--70",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "1",

}

TY - JOUR

T1 - Stereotactic core needle biopsy of multiple sites in the breast

T2 - Efficacy and effect on patient care

AU - Rosenblatt, Ruth

AU - Fineberg, Susan A.

AU - Sparano, Joseph A.

AU - Kaleya, Ronald N.

PY - 1996/10

Y1 - 1996/10

N2 - PURPOSE: To evaluate the efficacy and effect on patient care of performing stereotactic core needle biopsy of more than one site in the presence of multiple breast lesions. MATERIALS AND METHODS: Twenty-five patients underwent stereotactic core needle biopsy of more than one site. Histologic findings at core biopsy were correlated with mammographic findings, subsequent surgical results, and clinical follow-up. RESULTS: The final pathologic results were malignant in 15 (60%) patients. Invasive duct carcinoma or duct carcinoma in situ or both were diagnosed at more than one site and necessitated mastectomy in 10 patients (group I). Benign lesions were found at all sites in 10 patients (group II). Duct carcinoma in situ at only one site or atypical duct hyperplasia at one or more sites was documented in three patients, two of whom underwent breast conservation surgery (group III). Multisite stereotactic core needle biopsy had a positive effect on patient care in 20 (80%) of 25 patients by either helping to confirm the need for mastectomy without requiring needle localization biopsy (group I) or by documenting benign disease and sparing the patient needle localization biopsy at one or more sites (group II). CONCLUSION: Multisite stereotactic core needle biopsy is feasible, safe, and may influence treatment in patients with multiple mammographic abnormalities.

AB - PURPOSE: To evaluate the efficacy and effect on patient care of performing stereotactic core needle biopsy of more than one site in the presence of multiple breast lesions. MATERIALS AND METHODS: Twenty-five patients underwent stereotactic core needle biopsy of more than one site. Histologic findings at core biopsy were correlated with mammographic findings, subsequent surgical results, and clinical follow-up. RESULTS: The final pathologic results were malignant in 15 (60%) patients. Invasive duct carcinoma or duct carcinoma in situ or both were diagnosed at more than one site and necessitated mastectomy in 10 patients (group I). Benign lesions were found at all sites in 10 patients (group II). Duct carcinoma in situ at only one site or atypical duct hyperplasia at one or more sites was documented in three patients, two of whom underwent breast conservation surgery (group III). Multisite stereotactic core needle biopsy had a positive effect on patient care in 20 (80%) of 25 patients by either helping to confirm the need for mastectomy without requiring needle localization biopsy (group I) or by documenting benign disease and sparing the patient needle localization biopsy at one or more sites (group II). CONCLUSION: Multisite stereotactic core needle biopsy is feasible, safe, and may influence treatment in patients with multiple mammographic abnormalities.

KW - Breast neoplasms, diagnosis

KW - Breast, biopsy

KW - Breast, surgery

KW - Stereotaxis

UR - http://www.scopus.com/inward/record.url?scp=0029790750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029790750&partnerID=8YFLogxK

M3 - Article

C2 - 8816522

AN - SCOPUS:0029790750

VL - 201

SP - 67

EP - 70

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 1

ER -